Articles

  • 1 week ago | chemistryworld.com | Anthony J. King

    The spotlight was recently shone on the work culture of Chinese universities earlier this year following the death of a professor of materials science, aged 47, at Zhejiang University. The family blamed an ‘insane’ workload for the death of Liu Yongfeng from cerebral haemorrhage, according to the South China Morning Post. An open letter posted online by his wife calculated his working hours between March 2024 and 20 January this year.

  • 2 months ago | chemistryworld.com | Anthony J. King

    Decision ends pharmacies’ permission to prepare versions of GLP-1 hormone mimicsNovo Nordisk’s semaglutide diabetes and weight loss drugs, Ozempic and Wegovy, are no longer officially in shortage in the US, according to the US Food and Drug Administration (FDA). That means that compounding pharmacies and outsourcing facilities that had been legitimately preparing their own versions of the drugs will no longer be permitted to do so.

  • 2 months ago | nature.com | Anthony J. King

    It is tough for a person to find out that they have a progressive disease, especially when it threatens to rob them of their independence. With age-related macular degeneration (AMD) — the leading cause of vision loss among older people — a person faces a gradual and irreversible loss of vision, until they might no longer be able to recognize even a loved one.

  • 2 months ago | nature.com | Anthony J. King

    Drug discovery is extraordinarily difficult. “In 100 years or so of contemporary medicine, we’ve found treatments for only around 500 of the roughly 7,000 rare diseases,” says David Pardoe, a computational chemist at Evotec, a biotechnology company in Hamburg, Germany. “It takes too long and costs too much.” But in theory, and to the excitement of many, artificial intelligence (AI) could address both of these problems.

  • 2 months ago | chemistryworld.com | Anthony J. King

    Firms looking to cut costs, increase oil and gas production and cut renewable investments Source: © Luke Sharrett/Bloomberg/Getty Images Oil giant Chevron is to slash its workforce by 15– 20% by the end of 2026, losing up to 9000 jobs. The goal is to simplify the company’s structure and reduce annual costs by around $2–3 billion (£1.6–2.4 billion). Chevron is not alone. In January, BP began cutting around 4700 employees, around 5% of its workforce, and 3000 contractors – again to reduce costs.

Contact details

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →

X (formerly Twitter)

Followers
713
Tweets
431
DMs Open
Yes
Anthony King
Anthony King @AntonyJKing
28 Feb 25

RT @ChemistryWorld: ‘This study is a stark reminder of just how prevalent toxic chemicals are in the environment and the damaging impact th…

Anthony King
Anthony King @AntonyJKing
16 Feb 25

RT @ChemistryWorld: For the first time in decades, a new class of painkiller has been approved by the US Food and Drug Administration. Vert…

Anthony King
Anthony King @AntonyJKing
13 Feb 25

RT @ChemistryWorld: Swiss researchers monitored cell growth and quantified changes in 2269 putative metabolites produced by lung cancer cel…